Healthcare & Life Sciences
Remedy Pharmaceuticals, Inc.
United Stateswww.remedypharmaceuticals.com/
series-a
series-a
Stage
1
Investors
About
Remedy Pharmaceuticals develops CIRARA, a drug candidate designed to reduce cerebral edema and improve functional outcomes in patients suffering from Large Hemispheric Infarction (massive ischemic stroke).
Explore Remedy Pharmaceuticals, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.